Cargando…
Successful treatment with temozolomide in an elderly woman with advanced pulmonary large-cell neuroendocrine carcinoma: A case report
RATIONALE: Pulmonary large-cell neuroendocrine carcinoma (LCNEC) is a rare type of lung cancer, and 40% of patients are in stage IV at initial diagnosis. It has an extremely poor prognosis with a 1-year survival rate of 27%. Patients with LCNEC are predominantly male, older, and heavy smokers. There...
Autores principales: | Wei, Juan, Dong, Xiao Fang, Hu, Zu Liang, Tang, Sheng, Lu, Yi Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320007/ https://www.ncbi.nlm.nih.gov/pubmed/30572435 http://dx.doi.org/10.1097/MD.0000000000013318 |
Ejemplares similares
-
Pulmonary large cell carcinoma with neuroendocrine morphology shows genetic similarity to large cell neuroendocrine carcinoma
por: Liang, Zuoyu, et al.
Publicado: (2022) -
Post first-line dacarbazine or temozolomide in neuroendocrine carcinoma
por: Couronne, Thomas, et al.
Publicado: (2020) -
Outcomes of Capecitabine and Temozolomide (CAPTEM) in Advanced Neuroendocrine Neoplasms (NENs)
por: Thomas, Katharine, et al.
Publicado: (2020) -
Pulmonary large cell neuroendocrine carcinoma with adrenal oligorecurrence successfully treated by adrenalectomy
por: Sato, Hiroki, et al.
Publicado: (2020) -
Pulmonary Large Cell Neuroendocrine Carcinoma
por: Yang, Lan, et al.
Publicado: (2022)